Best Insurance Stocks To Buy Right Now

Trump’s CMS Posts 2018 Medicare Premiums

Trumps Treasury Proposes Too Big to Fail Changes

4 Things to Tell Older Clients About Their Life Insurance

The White House wouldn’t oppose removing from the Senate tax plan a controversial provision to repeal the individual health care mandate of the Affordable Care Act, budget director Mick Mulvaney said, a move that could help secure the vote of key Republicans.

The provision could be dropped if it becomes “an impediment,” Mulvaney, head of the Office of Management and Budget (OMB), said on CNN’s “State of the Union.”

“If we can repeal part of Obamacare as part of a tax bill and have a tax bill that is still a good tax bill that can pass, that’s great,” he said. “If it becomes an impediment to getting the best tax bill we can, then we’re OK with taking it out.”

(Related: Muddled White House Tax Message Clouds Pitch for Trump Plan)

Best Insurance Stocks To Buy Right Now: CVS Health Corporation(CVS)

Advisors’ Opinion:

  • [By Keith Speights]

    CVS Health (NYSE:CVS) reported its fourth-quarter financial results on Thursday. The big pharmacy services company beat its guidance, helped primarily by a strong performance from its pharmacy benefits management (PBM) segment. The bar had been lowered, however, because CVS reduced its fourth-quarter projections three months ago in light of contract losses to Walgreens Boot Alliance (NASDAQ:WBA).


    Target (TGT) had missed projections for the last couple of quarters and didn’t have as strong growth online as some were looking for. Plus, when CVS (CVS) reported its miserable call, the stock got blasted because CVS said its drugstores in Target weren’t anything to write home about. So Target didn’t participate in the great retail rally that we had last week. Now it is front and center after that stronger-than-expected quarter. And make no mistake about it, that quarter was stronger than expected. (Disney and CVS are part of TheStreet’s Trifecta Stocks portfolio.)

  • [By Brian Feroldi]

    Investors in CVS Health(NYSE:CVS) should be quiterelieved to finally put 2016 in the rearview mirror. Shares of the retail pharmacy giant fell by more than 18% during 2016, according to data fromS&P Global Market Intelligence. That vastly underperformed the company’s biggest rival,Walgreens Boots Alliance (NASDAQ:WBA).


    CVS Health (CVS) is a long-term winner, returning more than 14% a year over the past decade, double the yearly return of the S&P 500. It has sold off from over $110 this past summer to a recent $93, presenting a buying opportunity. The decline stems in part from management last quarter issuing 2016 earnings guidance below Wall Street expectations. Even so, it implies earnings per share growth of 10% to 14% next year. Shares now sell for 16 times projected earnings for the next four quarters, down from close to 20 times earlier this year.

    The company remains at the center of trends that could keep earnings growing at a double-digit pace through the end of the decade. Increased medical-plan coverage is driving more prescriptions. So is the aging of the baby boomers. Medical plans are looking to save on drugs, and some are turning over more business to drug-plan managers like CVS’ Caremark. Patients looking for savings, including those who remain uninsured, can take care of basic health-care needs through walk-in clinics, like CVS’ Minute Clinic chain. The stock’s dividend yield is unremarkable at 1.5%, but payments are expected to grow more than 60% cumulatively over the next three years. 
  • [By Keith Speights, Sean Williams, and Cory Renauer]

    So when we asked three of our top healthcare contributors to name three of the best stocks to invest in healthcare, it’s not surprising that their responses listed companies in three different industries: medical device makerMasimo (NASDAQ:MASI), pharmacy services giant CVS Health (NYSE:CVS) and biopharmaceutical company Ligand Pharmaceuticals (NASDAQ:LGND). Here’s why these three healthcare stocks stand out as smart picks.

  • [By Michael K. Farr]

    CVS Health sold off from its high of over $113 to $92 recently as the company issued 2016 guidance that was below expectations. Only six weeks later, CVS increased its outlook for 2016, causing the stock to rally off recent lows to where it currently sits at around $98. We believe CVS offers value because of its undemanding valuation, its focus on returning capital to shareholders, and its exposure to long-term secular tailwinds, including increased health-care coverage, an aging population, and healthcare cost control.

    Management recently reaffirmed its long-term target of 10-14 percent EPS growth while also increasing its dividend 21 percent to $1.70 (to a 1.7 percent yield). CVS is committed to increasing its dividend payout ratio to 35 percent by 2018, which implies a compound annual growth rate of 18 percent. Also, we expect $4 billion to $5 billion in share repurchases annually. CVS currently trades at 16.9 times calendar year 16 estimated EPS. 

Best Insurance Stocks To Buy Right Now: SPDR Blmbg Barclays Intl Trs Bd ETF (BWX)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI also holds the SPDR Barclays Emerging Markets Local Bond ETF (NYSE: EBND), SPDR Barclays International Treasury Bond ETF (NYSE: BWX) and the SPDR Barclays Intermediate Term Corporate Bond ETF (NYSE: ITR).

Best Insurance Stocks To Buy Right Now: Vince Holding Corp.(VNCE)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap upscale apparel brandretailer Vince Holding Corp (NYSE: VNCE) reported Q1 2017 financial results before the market opened this morning. Net sales decreased 14.2% to $58.0 million as wholesale segment sales decreased 20.9% to $35.4 million, primarily due to a reduction in full-price orders as a result of the elimination of the Companys summer delivery, and asdirect-to-consumer segment salesfell 1.0% to $22.6 million. Comparable sales decreased 5.7%, including e-commerce sales, due to a decrease in average order value.

  • [By Lisa Levin]

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 15 percent to $3.67. Vince Holding projects full-year sales and EPS to come in at or below the low end of its earlier issued outlook.

  • [By Lisa Levin]

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 41 percent to $0.800. Vince Holding reported a Q4 loss of $162.1 million on revenue of $63.9 million.

Leave a Reply

Your email address will not be published.